You are currently viewing a new version of our website. To view the old version click .
Proceedings
  • Abstract
  • Open Access

15 November 2017

Novel Anticancer Capacities of Saffron †

Biology Department, UAE University, Abu Dhabi 15551, United Arab Emirates
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
This article belongs to the Proceedings Proceedings of the 2nd International Conference on Natural Products for Cancer Prevention and Therapy

Abstract

Thanks to poor diagnosis and very limited treatment options, hepatocellular carcinoma (HCC) continues to lead the list of cancer-leading causes of death worldwide. Therefore, alternative therapy is crucial to control HCC. Our group has investigated the anticancer effects of the saffron’s main active ingredient “safranal” against HCC using in vitro, in silico, and network analyses. In addition to the unique and differential cell cycle arrest, safranal showed pro-apoptotic effect through activation of both intrinsic and extrinsic initiator caspases implicating ER stress-mediated apoptosis. Gene set enrichment analysis provided consistent findings where unfolded protein response (UPR) was among the top terms in up-regulated genes in response to safranal treatment. Thus, proteins involved in ER stress and autophagy were regulated through safranal treatment to induce UPR and autophagy-mediated cell death in HepG2 cells.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.